Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107493 · ClinicalTrials.gov registry record · NA
Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)
A NA study, sponsored by ResMed.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT04107493 is a NA study that has completed, run by ResMed. The registered enrollment target is 33 participants.
The verdict
NCT04107493, a NA study, has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Prospective randomized study with a cross-over design. Mobi™ is a relatively new POC in the market and thus it is valuable to collect data from COPD patients using supplemental oxygen, and their use on Mobi™. The purpose of the present study is to compare Mobi™ with a continuous flow oxygen cylinder, with SpO2 as the primary endpoint.
Interventions
- DEVICE Portable Oxygen Cylinder
- DEVICE Mobi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2020-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04107493
The ClinicalTrials.gov registry entry for NCT04107493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Portable Oxygen Cylinder is the first listed.
NCT04107493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04107493 about?
NCT04107493 is a clinical study titled "Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)". Prospective randomized study with a cross-over design. Mobi™ is a relatively new POC in the market and thus it is valuable to collect data from COPD patients using supplemental oxygen, and their use on Mobi™. The purpose of the present study is to compare Mobi™ with a continuous flow oxygen cylinder...
What is the current status of trial NCT04107493?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-11-21. Estimated completion is 2020-03-09.
What interventions are being tested in trial NCT04107493?
The interventions under investigation include: Portable Oxygen Cylinder (DEVICE), Mobi (DEVICE).
Who is sponsoring clinical trial NCT04107493?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.